SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-134053
Filing Date
2021-11-04
Accepted
2021-11-04 08:13:13
Documents
13
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2131148d2_8k.htm   iXBRL 8-K 26777
2 EXHIBIT 99.1 tm2131148d2_ex99-1.htm EX-99.1 61011
  Complete submission text file 0001104659-21-134053.txt   272564

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA repl-20211104.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE repl-20211104_lab.xml EX-101.LAB 34594
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE repl-20211104_pre.xml EX-101.PRE 22715
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2131148d2_8k_htm.xml XML 3595
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 211378133
SIC: 2836 Biological Products, (No Diagnostic Substances)